Pathophysiology Grants

The Education Scientific Assembly (ESA) of the American Society for Clinical Laboratory Science announces the competition for CLS/CLT student research papers and case studies. Student Research Papers should address scientific as well as applicable educational, technical, administrative, consulting, and management studies. Case Studies should address any unusual, interesting, and unique manifestation of a disease etiology, pathology, clinical syndrome, complications and prognosis known or unknown.

Eligibility

Research Paper: Student must be a current ASCLS member and have been enrolled in a NAACLS accredited CLS/CLT program at the time the research was conducted.

Case Studies: Student must be a current ASCLS member and presently enrolled in a NAACLS accredited CLS/CLT program. Case Studies should be from actual patient cases and address any unusual, interesting, and unique manifestation of a disease etiology, pathology, clinical syndrome, complications and prognosis known or unknown.

Awards

Research paper: Travel expenses to the ASCLS national meeting. Paid expenses include airfare, registration, and single room for the duration of the meeting

Case Study: $500 cash award.

Conditions

The student winning the research paper award will present their paper during the ASCLS national meeting. The student awards will be presented at the awards ceremony during the ASCLS national meeting.

Students can also submit their papers/cases to the journal Clinical Laboratory Science to be reviewed for publication.

Research papers/cases will be judged according to guidelines in Instructions to Authors for the journal Clinical Laboratory Science. Failure to follow guidelines will result in rejection from judging.

Review of the paper/case will be anonymous. Designated representatives of the ESA will review papers/cases. Reviewers are expected to disqualify themselves if a paper/case is from their institution or there is a conflict of interest. Reviewers should abstain from grading if the subject is outside the reviewer(s) area of expertise. Authors will be notified by mail of awards soon after the review process. Date and time of research paper presentation will be included in the notification letter.

Papers/cases that are not dated by the deadline will be rejected without review and the submitter(s) will be notified.
By May 1:

* Fax one signed copy of the application cover sheet to Joan Polancic, ASCLS Director Education at 303-904-8933. Click here to print a MS-Word file of the cover sheet.
* Email one copy of the research paper or case study (Word or Word Perfect format) to joanp@ascls.org. Include the research paper or case study title, author name, and institution address on the paper's coversheet.

Deadline
May 1

Send to:
Joan Polancic
ASCLS Director of Education
fax: 303-904-8933
joanp@ascls.org

Criteria for Judging Research Papers

Research papers will be judged according to guidelines in Instructions to Authors. Click here to print a MS-Word copy of Instructions to Authors.
Basis of Grading Scale:

1. Overall assessment of the investigation’s applicability and inherent value to CLS practitioners.
2. The validity of the author’s conclusion in reference to the hypothesis of problems, statistical findings, and their level of significance.
3. Organization of the paper.
4. Adherence to format in published instructions

Criteria for Grading a Case Study
Case studies will be judged according to guidelines in "Instructions to Authors."

Scientific Merit

* Case demonstrates extensive study of the subject (population), a valuable contribution to Clinical Laboratory Science/Clinical Laboratory Technology profession, allied health education, health care, and medicine.
* Case represents uncommon disease condition, outcome of disease, unusual complications, education or management outcome and/or methodology.
* Case study is clearly and thoughtfully organized, ideas well defined and comprehensive.
* Interpretation of the case is presented sufficiently with implications for its relevance for clinical application or valuable contribution to the clinical laboratory science practice and profession.

Format and Presentation

* Writing shows good clarity, broad and precise vocabulary attuned to the scientific discipline and correct grammatical usage.
* Patient history and disease condition and/or new innovative practice are described.
* Main outcome measurements reflect the impact of achieving patient outcomes stated with adequate clarity.
* All aspects of instructions to authors are followed.

Preparation of Copy

All case studies/research papers must be double-spaced and typed with margins of 1 inch on all edges. Cover page must be included; no abstract is required for initial submission. Recommended typeface is Times New Roman, 12-point type. Text format is flush left. To encourage consistency in style refer to guidelines in "Instructions to Authors."

ASIP Experimental Pathologist-in-Training Award

Application Deadline: November 12, 2008

The EPIT is a prestigious award presented to an ASIP trainee member who is a postdoctoral fellow (including research and clinical fellows) and who has excelled in investigative efforts in studying mechanisms of disease, as evidenced by an abstract submission to the ASIP annual meeting, an extended research report, and a letter of recommendation attesting to the candidate’s role in the work and potential as a biomedical research investigator. The award includes: a certificate of achievement for the winning abstract presented at the ASIP Annual Meeting Awards Presentation at the Experimental Biology Meeting, a $1,500 honorarium and complimentary meeting registration.

Candidates for the EPIT Award are also considered for ASIP Merit Awards ($1,250 plus complimentary registration), which will be awarded to the best postdoctoral fellow/resident abstract. Each applicant must be a trainee member of ASIP. Prior recipients of the EPIT and Merit Awards may reapply if the work submitted is clearly distinct from the work previously submitted for their winning application (not just a continuation of the same project). In such cases, the applicants should submit a copy of the previous winning application along with the new application.

American Society for
Investigative Pathology
9650 Rockville Pike
Bethesda, MD 20814 (USA)
Tel: 301-634-7130
Fax: 301-634-7990
www.asip.org

Deafness Research Foundation Centurion Clinical Research Award Grant

Open to those holding MD, PhD, or equivalent degrees and a faculty or post-doctoral appointment in the U.S to support clinical research projects in hearing and balance science including diagnosis, epidemiology, clinical pathophysiology, and treatment. One year, non-renewable. $50,000 maximum. One available annually.

The purpose of this award is to support clinical research projects in hearing and balance science
Clinical research involves human participants and may be directed toward diagnosis, epidemiology,
genetics, clinical pathophysiology, and treatment.
ELIGIBILITY
Candidates for this award should hold the M.D., Ph.D., or equivalent degrees as well as a faculty or postdoctoral
appointment and demonstrate experience and strong research training as well as sufficient
institutional support (facilities, time, and mentorship) to carry out the proposed work. Ideal candidate
should be is in their first 5 years after completion of formal training. A faculty mentor should be identified
and a letter of support and availability should be included in the application. Previous DRF or AAO-HNS
Foundation research grant recipients are eligible to compete for this grant. However, candidates who
have successfully obtained funding from a private or federal funding agency for the same research are
ineligible. Candidates who have applied for support of the same research from other funding sources, and
who are notified of an award from both another agency and from AHRF must choose only one of the
awards.
CONDITIONS
Research supported by this award should be specifically directed toward the clinical identification,
diagnosis, prevention, or treatment of diseases, disorders, or conditions of the ear. While not specifically
required, proposals which aim to introduce new knowledge and methodology from other disciplines to
research in otology or neurotology, or which demonstrate collaborative effort with members of other
related disciplines are encouraged. Projects must be designed to yield useful information within the period
of award, but priority will be given to projects that are also innovative with promise to develop into new
long-range or expanded research programs capable of attracting funding from other sources.
The grant application must be accompanied by letters of support from the Chair of the candidate’s
academic department. These letters are to indicate a general level of support of the applicant, and to
demonstrate the fact that the department will make time, space, and other resources accessible for
completion of the project. Applicants must obtain letters of support/understanding from all key personnel
on the project.
TERMS
1. Amount: $50,000 maximum
2. Period: 12 months, non-renewable

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

American Laryngological Association/American Laryngological Voice and Research Education Foundation Award

The purpose of this award is to support basic, translational, or clinical research projects in laryngology,
voice, outcomes, and related subjects.
B. ELIGIBILITY
Candidates for this award should be otolaryngologists who have completed their training at an ACGME
accredited program in otolaryngology - head and neck surgery. The principal investigator should be a
physician faculty member of a recognized department, division, or section of otolaryngology-head and
neck surgery. Previous ALA or AAO-HNS Foundation research grant recipients are eligible to compete for
this grant. However, candidates who have successfully obtained funding from a private or federal funding
agency for the same research are ineligible. Candidates who have applied for support of the same
research from other funding sources, and who are notified of an award from both another agency and
from ALA must choose only one of the awards.
C. CONDITIONS
Research supported by this award should be specifically directed toward the pathogenesis,
pathophysiology, diagnosis, prevention, or treatment of diseases, disorders, or conditions of the larynx
and may be either basic or clinical/translational in approach. While not specifically required, proposals
which aim to introduce new knowledge and methodology from other disciplines to research in laryngology
or neurolaryngology, or which demonstrate collaborative effort with members of other related disciplines
are encouraged. Projects must be designed so as to yield useful information within the period of award,
but priority will be given to projects that are also innovative with promise to develop into new long-range
or expanded research programs capable of attracting funding from other sources. The grant application
must be accompanied by letters of support from the Chair of the candidate’s academic department.
These letters are to indicate a general level of support of the applicant, and to demonstrate the fact that
the Department will make time, space, and other resources accessible for completion of the project.
D. TERMS
1. Amount: $10,000 maximum. The foundation will consider requests to cover travel expenses up to
$1000 for the principal investigator to present his/her results at the ALA annual meeting.
2. Period: 12 months, non-renewable

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

American Head and Neck Society Alando J. Ballantyne Resident Research Pilot Grant

For the best grant application by a resident in the U.S. or Canada. One year, non-renewable, $10,000, one available annually.

The purpose of this award is to support basic, translational, or clinical research projects in head and neck
oncology. Clinical or translational research studies are strongly encouraged and should be specifically
related to the prevention, diagnosis, treatment, outcomes, or pathophysiology of head and neck
neoplastic disease. The Alando J. Ballantyne Resident Research Pilot Grant memorializes Alando J.
Ballantyne, M.D., a giving teacher, dedicated surgeon, and a devoted husband and father.
ELIGIBILITY
This grant is open to resident in U.S. or Canadian training programs. Previous AHNS or AAO-HNS
Foundation research grant recipients are eligible to compete for this grant. However, candidates who
have successfully obtained funding from a private or federal funding agency for the same research are
ineligible. Candidates who have applied for support of the same research from other funding sources, and
who are notified of an award from both another agency and from AHNS must choose only one of the
awards.
CONDITIONS
Research supported by this award should be specifically directed toward the pathogenesis,
pathophysiology, diagnosis, prevention, or treatment of head and neck neoplastic disease, and may be
either basic or clinical/translational in approach. While not specifically required, proposals which aim to
introduce new knowledge and methodology from other disciplines to research in head and neck disease,
or which demonstrate collaborative effort with members of other related disciplines are encouraged.
Projects must be designed so as to yield useful information within the period of award, but priority will be
given to projects that are also innovative with promise to develop into new long-range or expanded
research programs capable of attracting funding from other sources. The grant application must be
accompanied by letters of support from the Chair of the candidate’s academic department and from the
principal scientific advisor or mentor. These letters are to indicate a general level of support of the
applicant, the fact that the Department will make time, space, and other resources accessible for
completion of the project, and that the applicant will have appropriate supervision/support throughout the
period of the grant. Applicants must obtain letters of support/understanding from all key personnel on the
project.
TERMS
1. Amount: $10,000 maximum
2. Period: 12 months, non-renewable

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

American Head and Neck Society Pilot Grant

Open to Medical Students, residents, PhD, and junior faculty residing in the U.S. and Canada to support basic, translational, or clinical research projects in head and neck oncology. One year, $10,000, one available annually.

The purpose of this award is to support basic, translational, or clinical research projects in head and neck
oncology. Clinical or translational research studies are strongly encouraged and should be specifically
related to the prevention, diagnosis, treatment, outcomes, or pathophysiology of head and neck
neoplastic disease.
ELIGIBILITY
Candidates for this award should reside in the U.S. or Canada, be medical students, residents, Ph.D.s or
faculty members at the rank of associate professor or below. Previous AHNS or AAO-HNS Foundation
research grant recipients are eligible to compete for this grant. However, candidates who have
successfully obtained funding from a private or federal funding agency for the same research are
ineligible. Candidates who have applied for support of the same research from other funding sources, and
who are notified of an award from both another agency and from AHNS must choose only one of the
awards.
CONDITIONS
Research supported by this award should be specifically directed toward the pathogenesis,
pathophysiology, diagnosis, prevention, or treatment of head and neck neoplastic disease, and may be
either basic or clinical/translational in approach. While not specifically required, proposals which aim to
introduce new knowledge and methodology from other disciplines to research in head and neck disease,
or which demonstrate collaborative effort with members of other related disciplines are encouraged.
Projects must be designed so as to yield useful information within the period of award, but priority will be
given to projects that are also innovative with promise to develop into new long-range or expanded
research programs capable of attracting funding from other sources.
The grant application must be accompanied by letters of support from the Chair of the candidate’s
academic department and from the principal scientific advisor or mentor. These letters are to indicate a
general level of support of the applicant, the fact that the Department will make time, space, and other
resources accessible for completion of the project, and that the applicant will have appropriate
supervision/support throughout the period of the grant. Applicants must obtain letters of
support/understanding from all key personnel on the project.
TERMS
1. Amount: $10,000 maximum
2. Period: One year, non-renewable

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

Funding Opportunities

The Dystonia Medical Research Foundation (DMRF) encourages and supports research related to the causes, mechanisms, prevention, and treatment of all forms of dystonia, the third most common movement disorder. Through a peer-review process, all applications are reviewed and ranked by the DMRF’s Medical and Scientific Advisory Council, who then make recommendations to the Board of the Directors for funding.

Types of Awards

Fellowships
A two-year Fellowship is designed to assist post-doctoral fellows establish careers in research relevant to dystonia.

The DMRF supports hypothesis-driven research at the genetic, molecular, cellular, systems, or behavioral levels that may lead to a better understanding of the pathophysiology of dystonia or to new therapies for dystonia.

Funding for fellowships is $50,000 per year for two years.

Research Grants
Research grants are available in support of hypothesis-driven research at the genetic, molecular, cellular, systems, or behavioral levels that may directly or indirectly lead to a better understanding of the pathophysiology and to new therapies for any or all forms of dystonia. Although early-onset primary generalized dystonia is of special interest, we also support studies on the focal dystonias, including laryngeal dystonia/spasmodic dysphonia, as well as secondary dystonias.

Funding for grants is available up to $65,000 per year for 1 or 2 years.

The deadline for grant and fellowship applications is December 15, 2008. Applications and guidelines will be available September 15.

Dystonia Medical Research FoundationNational Headquarters
One East Wacker Drive, Suite 2810
Chicago, Illinois 60601-1905
Phone: 312-755-0198
Toll free: 800-377-DYST (3978)
In Canada: 800-361-8061
Fax: 312-803-0138
Email: dystonia@dystonia-foundation.org

Expertise Transfer Fellowship

The IARC is offering an Expertise Transfer Fellowship to enable an established investigator to spend normally from six to twelve months in an appropriate host institute in a low- / medium-resource country* in order to transfer knowledge and expertise in a research area relevant for the host country and related to the Agency's programmes: epidemiology, biostatistics, environmental chemical carcinogenesis, cancer etiology and prevention, infection and cancer, molecular cell biology, molecular genetics, molecular pathology and mechanisms of carcinogenesis.

Applications should include a proposed collaborative research project, specifying the link to IARC's on-going activities and a letter of support from the host lab giving details of feasibility and anticipated benefit to the receiving institute. A letter of endorsement from a research Group at IARC must also be provided. Priority will be given to projects directly linked to IARC's on-going research programme, involving at least one contact at IARC.

Applicants should be established cancer researchers actively engaged in the field with appropriate scientific or medical qualifications and an excellent publications' record. They must also belong to the staff of a university or a research institution.
Deadline for receipt of applications is: 30 November 2008

Candidates will be notified of the outcome of their application by the end of April 2009. There will be an annual remuneration of up to US$70,000, which will take into account the on-going salary of the Fellow. This amount may include limited support for the project. The cost of travel will also be met. The Award should be taken up no later than November 2009.

(*any country other than those classified as high-income economies by the World Bank)

Fellowship application forms and more detailed information are available from:

Fellowship Programme
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
150 cours Albert-Thomas, 69372 Lyon Cedex 08, France
Tel: +33 (0)472 73 84 48; Fax: +33 (0)472 73 80 80; E-mail: fel@iarc.fr

Dermatopathology Grant
The grant provides financial support for dermatopathology research projects that
benefit the specialty of dermatology.
Applicant Eligibility Requirements:
• M.D.; Ph.D.; M.D., Ph.D.; or D.O. degree
• Dermatologist or pathologist who will have completed a dermatopathology
fellowship in a division or department of dermatology, pathology or
dermatopathology at the time of funding, and is attempting to embark on a
research career. Research proposals may include bench research, classical
epidemiology, outcomes analysis or other approaches and should be clearly
related to advancing the field of dermatopathology
• Investigator in the early stages of career

To meet the application deadline, can my application be postmarked by October 15th?
No. To be considered for a 2009 research award, your complete research application must be
sent so that it is RECEIVED at the Foundation office on or before Wednesday, October 15,
2008. Your application should be sent to the following address:
Medical and Scientific Committee
Dermatology Foundation
1560 Sherman Avenue, Suite 870
Evanston, IL 60201-4808

The National Spasmodic Dysphonia Association is seeking research applications for new investigator startup grants or post doctoral study focused on research aimed at increasing understanding of Spasmodic Dysphonia, a focal dystonia with that affects speech.

Small seed money grants to new or established investigators for up to $20,000 (excluding indirect costs) per year will be awarded. These can be for startup grants enabling successful applicants to subsequently seek funding from the National Institutes of Health or may provide partial support for post doctoral research training relating to Spasmodic Dysphonia.

We are interested in hypothesis-driven research related to new approaches aimed at increasing understanding of Spasmodic Dysphonia that focuses on the following areas:

Endogenous and environmental risk factors for the development of Spasmodic Dysphonia
Pathophysiology of central nervous system dysfunction in Spasmodic Dysphonia
Animal models for Spasmodic Dysphonia
Novel approaches to the treatment of Spasmodic Dysphonia
Diagnostic tools for Spasmodic Dysphonia
Controlled studies of treatment outcomes in Spasmodic Dysphonia
The deadline to submit an application is January 15, 2009.

National Spasmodic Dysphonia Association
300 Park Boulevard, Suite 415, Itasca, IL 60143
Phone: 800-795-6732 Fax: 630-250-4505
Website: www.dysphonia.org